Neville Rodie & Shaw Inc Petros Pharmaceuticals, Inc. Transaction History

Neville Rodie & Shaw Inc

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Jan 05, 2022	SELL	$1.33 - $4.09 $29,093 - $89,468	-21,875 Closed	0 $0
Q4 2020 Mar 04, 2021	BUY	$3.24 - $4.68 $70,875 - $102,375	21,875 New	21,875 $96,000

Ticker PTPI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 20,708,000
Market Cap $6.42M
Description
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for th...

Get notified when there are updates to the investment portfolio of Neville Rodie & Shaw Inc, based on Form 13F filings with the SEC.

Stay updated on Neville Rodie & Shaw Inc with notifications on news.